Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001437749-25-019912·Ali Arif Nasir
Schedule 13D ownership disclosure
ENTERO THERAPEUTICS INC
Common stock, par value $0.0001 per share · CUSIP: 33749P408
Event date: 2025-06-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ali Arif NasirReported CIK 0002072056
Shares: 250,900.00 · Class: 5.3%
- Arif Ali IRA Roth
Shares: 147,900.00 · Class: 3.1%
- ANARP LLC
Shares: 82,800.00 · Class: 1.7%
- ANANRA LLC TRUST
Shares: 20,200.00 · Class: 0.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-25-019912
- Form type
- SCHEDULE 13D
- Filer
- Ali Arif Nasir
- CIK
- CIK 2072056
- Filed
- Jun 09, 2025
- Reporting period
- Jun 02, 2025
- Description
- Schedule 13D beneficial ownership